AbbVie (ABBV) Wins Health Canada Approval for Boey
AbbVie Inc. (NYSE:ABBV) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 23, 2026, …
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| المطلع | المنصب | التاريخ | النوع | القيمة |
|---|---|---|---|---|
| ROBERT J ALPERN | Director | May 26 '26 | Proposed Sale | 2781991,0 |
| Purdue David Ryan | SVP, Controller | Mar 04 '26 | Sale | 1221519,0 |
| David R. Purdue | Officer | Mar 04 '26 | Proposed Sale | 1221519,0 |
| Siatis Perry C | EVP, GC … | Mar 02 '26 | Sale | 4375549,0 |
| PERRY C SIATIS | Officer | Mar 02 '26 | Proposed Sale | 4375585,0 |
| Siatis Perry C | EVP, GC … | Feb 25 '26 | Option Exercise | 3863458,0 |
| Siatis Perry C | EVP, GC … | Feb 25 '26 | Sale | 5147630,0 |
| PERRY C SIATIS | Officer | Feb 25 '26 | Proposed Sale | 5147630,0 |
| Richard A. Gonzalez | Former Director | Aug 22 '25 | Proposed Sale | 13231264,0 |
| Richard A. Gonzalez | Former Director | Aug 21 '25 | Proposed Sale | 18993948,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر ABBV والمشاعر والاتجاه
AbbVie Inc. (NYSE:ABBV) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 23, 2026, …
For a solid yield and strong upside potential, this pharmaceutical stock is worth considering.
Ten years ago, AbbVie (NYSE:ABBV) was a one-drug story. Humira, the world’s best-selling medicine, threw off the cash that funded …
Over the past six months, AbbVie’s shares (currently trading at $211.15) have posted a disappointing 9.8% loss, well below the …
Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices …
AbbVie Inc. (NYSE:ABBV) is one of the top S&P 500 stocks by index weight. On April 13, AbbVie Inc. (NYSE:ABBV) …
تحليل متعدد المزودين بالذكاء الاصطناعي